• BX Home
  • King Pharmaceuticals (KG): Blog

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

KING PHARMACEUTICALS (KG)

King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.

King Pharmaceuticals (KG) is part of Business Exchange, suggested by Ginny Moore. This topic contains 196 news and 136 blog items. Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from like-minded professionals.

Blogs

Recent blog posts on this topic.

King Pharmaceuticals Advances as Battered Drug Firms Lure Private...more

Nov. 23 (Bloomberg) -- King Pharmaceuticals Inc., LifePoint Hospitals Inc. and Endo Pharmaceuticals Holdings Inc.

King Pharmaceuticals May Climb as Battered Drug Firms Lure Private...more

Nov. 23 (Bloomberg) -- King Pharmaceuticals Inc., LifePoint Hospitals Inc. and Endo Pharmaceuticals Holdings Inc.

Option Skews - Relatively Heavy Call Activity on Research in Motion...more

...of Saskatchewan, King Pharmaceuticals Inc...

Market Winners & Losers: King Pharmaceuticals, MBIAmore

The major indexes fell for the second day in a row, with the Dow closing down 0.9%, the S&P 500 falling 1.

Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG,more

King Pharmaceuticals Inc. (NYSE: KG) - hit $11.88. May be benefitting from mixed...

Earn Cash From King Pharmaceuticals (KG)'s New Highmore

King Pharmaceuticals (NYSE: KG) hit a new 52-Week high of $11.91 so far today.

King Recruitermore

Anyone know any recruiters who work with King?

Options Update: King Pharmaceuticals, Inc. (KG) and Headwaters Corp......more

Options Update: King Pharmaceuticals, Inc. (KG) and Headwaters Corp. (HW)

King Pharmaceuticals volatility low; shares near 14-month highmore

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare.....more

Fairfax Financial's Prem Watsa Buys General Electric Company, Zenith.....more

National Insurance, Sells Methanex Corp., King Pharmaceuticals Inc...

King Pharmaceuticals??, Inc. to Present at Healthcare Conferencemore

BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today announced plans...

King Pharmaceuticals Reports Strong Third Quarter 2009 Financial...more

King Pharmaceuticals (KG) NewsBite - KG Up Nearly 4% After Better...more

King Pharmaceuticals (NYSE: KG) opened at $10.30. So far today, the stock has hit a low of $10.30 and a high of $10.70.

King Pharmaceuticals, Inc (NYSE: KG): Third Quarter Earnings Preview.....more

King Pharmaceuticals, Inc is scheduled to report its fiscal third quarter 2009 financial results on Thursday, November...

King Pharmaceuticals reports profit fallmore

NEW YORK (MarketWatch) -- King Pharmaceuticals Inc.

King Pharmaceuticals??, Inc. Reports Profit Fallmore

Competitor Sues ZymoGenetics for False Advertising; Obtains Three...more

On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development,...

Earnings Preview: King Pharmaceuticalsmore

King Pharmaceuticals (KG) is expected to report Q3 earnings Thursday, November 5 before market open, with a conference...

King Pharmaceuticals??, Inc. Sues ZymoGenetics, Inc. Allegingmore

King Pharmaceuticals, Inc. et al v. Zymogenetics, Inc. et almore

Plaintiff: King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc, King Pharmaceuticals Research and Development, Inc.

King Pharmaceuticals Inc-Financial Company Report - research report...more

...com/Summary-Company-Profile/king-pharma...

King Pharmaceuticals??, Inc. Announces Date for Release of Third...more

BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that...

FDA Sends Warning Letter to King Pharmaceuticals Over Embeda Videosmore

...its website a warning letter send to King Pharmaceuticals over two Embeda video news releases. The letter is below.

FDA: King Pharmaceuticals??, Inc. Pain Drug Videos Misleadingmore

WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals' (KG.N) pain drug Embeda left out a...

Top Sources: King Pharmaceuticals (KG)

  • Finance, Investments n Trading
  • BlogNetNews.com » Tennessee
  • M2 PressWIRE: Latest Headlines
  • MarketIntelligenceCenter.com
  • optionMONSTER News
  • BioSpace.com Featured News
  • Analysen Ticker - www.finanzen.net
  • Bespoke Investment Group
  • BIOBUSINESS Financial Focus news from GEN
  • BIOBUSINESS Inside Industry news from GEN

Most Active Users in this Topic

No user contributions

Featured White Papers


Report comment contains invalid characters. ()
cancel
Search Cancel